Loading...
PhD Alja Štern

PhD Alja Štern
no.: 32094 source: ARIS

researcher – active in research organisation
E-mail alja.sternat signnib.si
Foreign language skills
Research activity

Code Science Field Subfield
1.08.00  Natural sciences and mathematics  Control and care of the environment   
4.06.00  Biotechnical sciences  Biotechnology   
Keywords
genetic toxicology, chemoprotective substances, advanced in vitro test systems, epigenetics, nanomaterials
Points
331.37
A''
63.8
A'
201.73
A1/2
211.87
CI10
592
CImax
223
h10
11
A1
1.19
A3
0.22
Data for the last 5 years (citations for the last 10 years) on June 19, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 19  669  593  31.21 
Scopus 21  746  657  31.29 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Biotechnical Faculty 2008 
Doctor's degree  Ph. D.   Genetics  SI University of Ljubljana, Biotechnical Faculty 2013 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  National Institute of Biology  Department of Genetic Toxicology and Cancer Biology  10/1/2019  Research associate  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J4-50147  Exploring the theranostic potential of aegerolysin-based protein complexes in combating bladder cancer   2023 - 2024  PhD Kristina Sepčić 
2. J2-50047  Plasma-assisted removal of emerging genotoxic contaminants from wastewater   2023 - 2024  PhD Martina Modic 
3. J1-4395  Development of novel multifunctional metal-oxide-based nanozymes and their toxicological characterisation (NaNoZymSafe)   2022 - 2024  PhD Bojana Žegura 
4. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors   2022 - 2024  PhD Andrej Perdih 
5. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič 
6. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour   2021 - 2024  PhD Alja Štern 
7. J1-2471  Chemical Carcinogenesis: Mechanistic Insights   2020 - 2024  PhD Urban Bren  80 
8. J1-2465  Advanced 3D cell models: Bridging the gap between in vitro and in vivo experimental systems (hep3DGenTox)   2020 - 2023  PhD Bojana Žegura 
9. L4-9325  Development of new, environment-friendly approaches for plant and human virus inactivation in waters   2020 - 2022  PhD Maja Ravnikar 
10. J4-1770  Plasma decontamination of mycotoxins and inactivation of fungi in food industry   2020 - 2022  PhD Martina Modic 
11. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   2020 - 2021  PhD Lucija Peterlin Mašič 
12. J1-8140  Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard in zdravje ljudi   2020  PhD Metka Filipič 
13. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2013  PhD Maja Čemažar 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   2020 - 2024  PhD Bojana Žegura 
2. P1-0245  Ekotoksiologija, toksikološka genomika in karcinogeneza (Slovene)   2009 - 2013  PhD Tamara Lah Turnšek 
Biography
Alja Štern graduated in Microbiology at the Biotechnical Faculty of the University of Ljubljana in September 2008. In October 2008 she enrolled in the doctoral study of Biological and Biotechnological Sciences at the Biotechnical Faculty of the University of Ljubljana, majoring in genetics. In October 2009 she became a young researcher at the National Institute of Biology (NIB) in Ljubljana, Department of Genetic Toxicology and Cancer Biology. She completed her PhD in 2013. From April 2013 to October 2019, Alja Štern was employed at Lek d.d. as researcher / researcher-expert at the department MS&T Laboratory, working in the field bioprocesses development and optimization, for the production of microbial secondary metabolites. Since 01.10.2019 she is employed at the National Institute of Biology in Ljubljana, at the Department of Genetic Toxicology and Cancer Biology as a research assistant.
Views history
Favourite